CPT code 68850 denotes the injection of contrast material into the tear duct (lacrimal system) to improve visualization on radiographic imaging. This diagnostic service is commonly used in evaluation of lacrimal drainage disorders, obstruction, or persistent epiphora, and is relevant to ophthalmology and radiology practices nationwide. The code matters nationally because it defines coverage, billing, and clinical documentation expectations for a specialized diagnostic procedure that may be performed in outpatient radiology suites, hospital radiology departments, or ophthalmology clinics with imaging capability.

Key payers in this context include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what the code represents, the typical clinical use and site of service, and what to expect in payer coverage discussions. The publication also summarizes common billing modifiers and practical considerations for claims processing, plus a concise clinical context for when lacrimal contrast injection is used.

What readers will learn: the clinical purpose of CPT code 68850, typical service settings, payer landscape nationally, and the billing context necessary to align documentation and coding for this diagnostic lacrimal imaging procedure.